Asia Pacific RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016–2021)

Asia Pacific RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016–2021)

ID: 4544 | Pages: 139 | November 2017 | Region: Asia Pacific


Asia Pacific RNA Analysis Market size was around USD 470 million in 2016. It is expected to grow at a CAGR of 14.5% to reach USD 930 million by 2021. It captures 25% of the global market. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines.

However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyse enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent.

Asia Pacific RNA Analysis Market segmentation by end user, type, and application. By end user the market is segmented into Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Centres. By type the market is segmented into Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, and RNAI Gene Silencing. Microarrays are further sub-segmented into Reagents, Instruments and Software. Polymerase Chain Reaction (PCR) is further sub-segmented into Reagents, Instruments and Software. Sequencing Technologies are further sub-segmented into Sanger Sequencing (Reagents, Instruments and Software), and Next Generation Sequencing (NGS) (Reagents, Instruments and Software). RNAI Gene Silencing is further sub-segmented into Reagents, Instruments and Software. By application the market is segmented into Clinical Diagnosis, Drug Discovery, and Toxic genomics. 

Asia Pacifc RNA Analysis Market geographical segmentation by India, China, Korea, Japan and others. But still, in the forecast period, emerging economies like Asia-Pacific (Japan, China, and India) are anticipated to form new revenue-generating pockets for the market players. Economic developments and increasing government funding to support new product developments are the major factors fuelling the growth of market in these regions.

The major RNA Analysis Market leaders are Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), and Thermofisher Scientific Inc. (U.S.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 End User                                                      

                                5.1.1 Introduction                                           

                                5.1.2 Academic Research & Government Institutes                                         

                                5.1.3 Pharmaceutical & Biotechnology Companies                                           

                                5.1.4 Hospitals & Diagnostic Centers                                       

                                5.1.5  Y-o-Y Growth Analysis, By End User                                            

                                5.1.6  Market Attractiveness Analysis, By End User                                          

                                5.1.7  Market Share Analysis, By End User                                            

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Microarrays                                            

                                                5.2.2.1 Reagents                              

                                                5.2.2.2 Instruments                        

                                                5.2.2.3 Software                              

                                5.2.3 Polymerase Chain Reaction (PCR)                                 

                                                5.2.3.1 Reagents                              

                                                5.2.3.2 Instruments                        

                                                5.2.3.3 Software                              

                                5.2.4 Sequencing Technologies                                 

                                                5.2.4.1 Sanger Sequencing                          

                                                                5.2.4.1.1 Reagents          

                                                                5.2.4.1.2 Instruments    

                                                                5.2.4.1.3 Software          

                                                5.2.4.2 Next Generation Sequencing (NGS)                        

                                                                5.2.4.2.1 Reagents          

                                                                5.2.4.2.2 Instruments    

                                                                5.2.4.2.3 Software          

                                5.2.5 RNAI Gene Silencing                                           

                                                5.2.5.1 Reagents                              

                                                5.2.5.2 Instruments                        

                                                5.2.5.3 Software                              

                                5.2.6 Y-o-Y Growth Analysis, By Type                                     

                                5.2.7 Market Attractiveness Analysis, By Type                                   

                                5.2.8 Market Share Analysis, By Type                                     

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Clinical Diagnosis                                   

                                5.3.3 Drug Discovery                                      

                                5.3.4 Toxicogenomics                                    

                                5.3.5 Y-o-Y Growth Analysis, By Application                                         

                                5.3.6  Market Attractiveness Analysis, By Application                                      

                                5.3.7  Market Share Analysis, By Application                                       

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By End User                        

                                                6.1.3.3 By Type                 

                                                6.1.3.4 By Application                    

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By End User                        

                                                6.1.4.3 By Type                 

                                                6.1.4.4 By Application                    

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By End User                        

                                                6.1.5.3 By Type                 

                                                6.1.5.4 By Application                    

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Affymetrix Inc.                                                          

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Agilent Technologies, Inc.                                                    

                8.3 Bio-Rad Laboratories, Inc.                                                    

                8.4 GE Healthcare                                                           

                8.5 Illumina, Inc.                                                              

                8.6 Qiagen N.V.                                                                

                8.7 F. Hoffmann-La Roche Ltd.                                                  

                8.8 Sigma-Aldrich Corporation                                                   

                8.9 Thermo Fisher Scientific, Inc.                                                              

                8.10 Fluidigm Corporation                                                           

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of end user, type and application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  2. Asia Pacific Microarray Market By Region, From 2016-2021 ( USD Billion )
  3. Asia Pacific PCR Market By Region, From 2016-2021 ( USD Billion )
  4. Asia Pacific Sequencing Market By Region, From 2016-2021 ( USD Billion )
  5. Asia Pacific RNAi Gene Silencing Market By Region, From 2016-2021 ( USD Billion )
  6. Asia Pacific RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  7. Asia Pacific Clinical Diagnostics Market By Region, From 2016-2021 ( USD Billion )
  8. Asia Pacific Drug Discovery Market By Region, From 2016-2021 ( USD Billion )
  9. Asia Pacific Toxicogenomics Market By Region, From 2016-2021 ( USD Billion )
  10. Asia Pacific RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
  11. Asia Pacific Pharmaceutical and biotechnology Companies Market By Region, From 2016-2021 ( USD Billion )
  12. Asia Pacific Academic Research and Government Institutes Market By Region, From 2016-2021 ( USD Billion )
  13. Asia Pacific Hospitals and Diagnostic Centers Market By Region, From 2016-2021 ( USD Billion )
  14. Japan RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  15. Japan RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  16. Japan RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
  17. China RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  18. China RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  19. China RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
  20. India RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  21. India RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  22. India RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
  23. Australia RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  24. Australia RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  25. Australia RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
  26. South Korea RNA Analysis Market By Technology, From 2016-2021 ( USD Billion )
  27. South Korea RNA Analysis Market By Applications, From 2016-2021 ( USD Billion )
  28. South Korea RNA Analysis Market By End-users, From 2016-2021 ( USD Billion )
Middle East And Africa Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU,...
Latin America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Asia Pacific Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Th...
Europe Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermogr...
North America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, O...
Middle East And Africa High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (T...
Latin America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
Asia Pacific High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Iden...
Europe High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identifica...
North America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identification, P...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.